Australia's most trusted
source of pharma news
Friday, 17 October 2025
In a major breakthrough in the way medicines are funded in Australia, the PBAC has recommended a broad listing for BMS' immunotherapy drugs Opdivo and Yervoy in advanced or metastatic cancers.